{"name": "Chelsea Therapeutics International",
 "permalink": "chelsea-therapeutics-international",
 "crunchbase_url": "http://www.crunchbase.com/company/chelsea-therapeutics-international",
 "homepage_url": "http://chelseatherapeutics.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "webemail06@chelseatherapeutics.com",
 "phone_number": "704-341-1516",
 "description": "",
 "created_at": "Wed Jul 21 02:54:15 UTC 2010",
 "updated_at": "Wed Jul 21 02:54:58 UTC 2010",
 "overview": "\u003Cp\u003EChelsea Therapeutics International, Ltd. is a development stage pharmaceutical company that focuses on acquiring, developing and commercializing products for the treatment of a variety of human diseases. The Company is developing a therapeutic agent for the treatment of symptomatic neurogenic orthostatic hypotension (NOH), and related conditions and diseases along with its development of prescription products for multiple autoimmune disorders, including rheumatoid arthritis, psoriasis, inflammatory bowel disease and cancer. As of December 31, 2009, it was focused on its drug development resources on two clinical stage development projects: droxidopa for symptomatic NOH and other potential indications, and its portfolio of non-metabolized antifolate compounds for the treatment of rheumatoid arthritis.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       26],
      "assets/images/resized/0009/4389/94389v1-max-150x150.png"],
     [[250,
       44],
      "assets/images/resized/0009/4389/94389v1-max-250x250.png"],
     [[282,
       50],
      "assets/images/resized/0009/4389/94389v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "President and CEO",
    "person":
     {"first_name": "Simon",
      "last_name": "Pedder",
      "permalink": "simon-pedder",
      "image": null}},
   {"is_past": false,
    "title": "CFO",
    "person":
     {"first_name": "J.Nick",
      "last_name": "Riehle",
      "permalink": "j-nick-riehle",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$16.8M",
 "funding_rounds":
  [{"round_code": "unattributed",
    "source_url": "http://www.irconnect.com/chtp/pages/news_releases.html?d=185267",
    "source_description": "Chelsea Therapeutics to Raise $18.2 Million in Registered Direct Offering",
    "raised_amount": 16820000.0,
    "raised_currency_code": "USD",
    "funded_year": 2010,
    "funded_month": 2,
    "funded_day": 26,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Venrock",
         "permalink": "venrock",
         "image":
          {"available_sizes":
            [[[150,
               52],
              "assets/images/resized/0001/6279/16279v1-max-150x150.jpg"],
             [[250,
               87],
              "assets/images/resized/0001/6279/16279v1-max-250x250.jpg"],
             [[351,
               123],
              "assets/images/resized/0001/6279/16279v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "3530 Toringdon Way",
    "address2": "Suite 200",
    "zip_code": "28277",
    "city": "Charlotte",
    "state_code": "NC",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo":
  {"valuation_amount": null,
   "valuation_currency_code": "USD",
   "pub_year": null,
   "pub_month": null,
   "pub_day": null,
   "stock_symbol": "NASDAQ:CHTP"},
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}